Adamas Pharma Revenue, Profits - ADMS Quarterly Income Statement

Add to My Stocks
$25.21 $0.29 (1.14%) ADMS stock closing price Jun 22, 2018 (Closing)

Financial analysis of Adamas Pharma involves more than just checking the Adamas Pharma stock price, by looking at the financial statements of the company in detail. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue increase to $2.55M for 2018 Q1 impacts the ADMS stock. Investors typically check year over year or quarter over quarter revenue growth. One also needs to look at Adamas Pharma assets, operating expenses and Adamas Pharma free cash flow. The Adamas Pharma profit and loss statement shows revenue of $2.55M for 2018 Q1. Revenue has grown by 0 QoQ for ADMS stock.

View and download details of revenue and profits for Adamas Pharma for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Adamas Pharma Revenues or Net Sales
2.55M---------
Cost Of Goods Sold (COGS)----------
Adamas Pharma Gross Profit
2.52M---------
Research & Development Expense7.18M6.46M6.45M7.17M7.08M7.06M7.43M9.22M7.52M9.7M
Selling General & Admin Expense26.36M23M16.06M13.11M9.14M8.29M7.34M8.05M6.64M6.9M
Income Before Depreciation Depletion Amortization-31.02M-28.89M-22.52M-20.28M-16.23M-15.3M-14.64M-17.06M-13.98M-16.07M
Depreciation Depletion Amortization----------
Non Operating Income----------
Interest Expense4.82M2.25M1.67M-------
Adamas Pharma Pretax Income
-34.97M-31.05M-23.36M-20.79M-16.02M-15.09M-14.39M-16.87M-13.82M-15.97M
Provision for Income Taxes--1.68M--0.05M--0.11M----5.27M
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-34.97M-29.36M-23.36M-20.75M-16.03M-14.96M-14.39M-16.88M-13.83M-10.69M
Extraordinary Items & Discontinued Operations----------
Adamas Pharma Profit/ Loss (Net Income)
-34.97M-29.36M-23.36M-20.75M-16.03M-14.96M-14.39M-16.88M-13.83M-10.69M
Average Shares used to compute Diluted EPS25.86M23.06M22.57M22.39M22.21M21.99M21.94M21.65M21.25M18.44M
Average Shares used to compute Basic EPS25.86M23.06M22.57M22.39M22.21M21.99M21.94M21.65M21.25M18.44M
Income Before Nonrecurring Items-34.97M-29.36M-23.36M-20.75M-16.03M-14.96M-14.39M-16.88M-13.83M-10.69M
Income from Nonrecurring Items----------
Adamas Pharma Earnings Per Share Basic Net
-1.35-1.27-1.04-0.93-0.72-0.68-0.66-0.78-0.65-0.58
Adamas Pharma Earnings Per Share Diluted Net
-1.35-1.27-1.04-0.93-0.72-0.68-0.66-0.78-0.65-0.58
EPS Diluted Before Nonrecurring Items-1.35-1.27-1.04-0.93-0.72-0.68-0.66-0.78-0.65-0.58
Preferred Dividends Acc Pd----------
Dividends Common0.000.00--------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Adamas Pharma stock analysis involves checking at least a few of the important things like:

  • Topline: A growing topline, as seen from the Adamas Pharma revenue chart, as is the case with Adamas Pharma indicates a growing business. One needs to compare the QoQ topline or sales growth of ADMS stock with its peers like AMPH stock and CBAY stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: Most businesses like Adamas Pharma try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called statement of revenue and expense. The ADMS financials along with Adamas Pharma historical stock prices provide a lot of details about the firm.

Adamas Pharma Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
208.95
Dividend Yield
0%